Subscribe to RSS - consent decree

consent decree

Invacare looks to stabilize in second half of 2017

 - 
08/08/2017

ELYRIA, Ohio – Invacare reported $233.5 million in net sales for the second quarter of this year compared to $275 million for the same period last year, a 15.1% decrease.

FDA lifts Invacare’s consent decree

Decree has handicapped company since late 2012
 - 
07/25/2017

ELYRIA, Ohio – Invacare has the green light to make and sell products again from its Taylor Street manufacturing facility and corporate headquarters here, the company announced July 25.

Invacare clear for re-inspection

 - 
04/28/2017

ELYRIA, Ohio – Invacare has completed the final milestones required to lift a consent decree with the U.S. Food and Drug Administration, paving the way for a re-inspection, the company announced April 27.

Invacare can resume design activities

 - 
04/18/2017

ELYRIA, Ohio – Invacare has been given the green light to resume design activities, according to a Form 8-K filed with the Securities and Exchange Commission.

Invacare shifts into phase two of transformation

 - 
02/10/2017

ELYRIA, Ohio – 2016 was the year Invacare tore itself down and 2017 will be the year it starts building itself back up, Matt Monaghan said during a conference call Feb. 9 to discuss the company’s fourth quarter and year-end financial results.

Invacare earnings show signs of ‘re-orientation’

 - 
02/09/2017

ELYRIA, Ohio – Invacare has reported net sales of $264.7 million for the fourth quarter of 2016 compared to $283.3 million for the same period in 2015. It reported net losses of $17.6 million vs. $2.93 million.

Change of focus drives improvements at Invacare

‘We are really not about the consent decree,’ top exec tells investors
 - 
08/05/2016

ELYRIA, Ohio – Invacare is holding tight to an improvement in gross margin for its beleaguered North America HME division as a sign that its turnaround efforts are paying off.

Invacare readies to submit final report to FDA

 - 
02/12/2016

ELYRIA, Ohio – Invacare could be turning the corner on its “ongoing journey” to lift a consent decree with the Food and Drug Administration that has handicapped the company since late 2012.

Invacare auditor submits third report

 - 
02/11/2016

ELYRIA, Ohio – Invacare’s independent auditor this week issued its certification report for the third phase of the consent decree indicating substantial compliance to the FDA’s quality system regulation.

Invacare receives feedback from FDA

 - 
12/18/2015

ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Pages